PMVP
Pmv Pharmaceuticals Inc
Precision oncology company developing p53-targeted therapies
CUSIP: 69353Y103HealthcareUS1 holder
Total Value
$68.62M
Total Shares
2.09M
Net Share Change
-277.8K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$68.62M2.09M shares
TRIM-277.8K(-11.8%)